2016 The 1st Symposium on The Development of Bio - medicine and The Exchange of Overseas Returnees

"The first biomedical frontiers in biomedical forum and overseas returnees seminar co sponsored by the" 100 graph Orsay and biomedical park in Yizhuang, the meeting will focus on "tumor immunity and cell therapy" and "gene editing technology" and "stem cell and regenerative medicine" three themes to communicate. The meeting will be invited from Beijing, Shanghai, Boston, San Francisco and other biological pharmaceutical R & D centers around the world colleagues to discuss the latest developments and future trends in the field of biological medicine. At the meeting to build a communication platform for struggle provides an academic exchange in the field of biological medicine various researchers, knowledge and opportunities of collision platform, to jointly promote the development of global biomedical research and bio pharmaceutical industry. In academic exchanges, the organizers will strive to create a relaxed atmosphere, the field of new and old friends in the field of biological medicine gathering stage.

First, the original intention of the meeting
Young, we with the love of life science and faith to the other side of the ocean to pursue a dream. After returning, whether it is engaged in basic research in universities, or in the bio pharmaceutical companies engaged in research and development work, still did not forget the beginning of the heart, in the love of the life sciences, for human health and hard work, for the bio pharmaceutical industry in our country to struggle. Scientific research needs the exchange and collision of ideas, to build a broad platform for resource sharing and common development. Whether you have been in Boston, San Francisco or in other areas of study or work, 100 Aosai figure and we sincerely invite you to meet in Beijing in September. Let us together, miss some people, a past, a period of time we together through the years. Let us get together, talk about research ideas, talk about medical research and development, to explore the academic, looking to the future!

The two part, invited experts lineup
Ye Lilin: Professor of Third Military Medical University, doctoral tutor. Research direction: viral and tumor immunity.
Li Feng: general manager of Beijing Tian Guang real biotech Limited by Share Ltd. Company research direction: research and development of gene engineering antibody drugs.
Xu Ting: President / Chairman of Suzhou Corelle Jerry Biotechnology Co., Ltd., a visiting professor at Jilin University and a researcher at the Shanghai Institute of medicine. In 2011, the international famous scholar Jerry and Corelle jointly set up in the field of tumor immune target Ding Fu Biotech Corp, focus on tumor immunotherapy.
Li Jinsong: Institute of Biochemistry and cell biology, Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai Institute of Biochemistry and cell biology, research group leader, doctoral tutor. Cell reprogramming and embryonic development.
Wang Haoyi: head of the Institute of genetic engineering technology, Institute of animal science, Chinese Academy of Sciences, research fellow. Research field: development and application of genetic engineering technology and epigenetic modification technology.
Wei Wensheng: College of life science, Peking University, biochemical and molecular biology. Field of study: eukaryotic genome editing and high throughput functional genomics, molecular mechanisms of disease and infection.
Gao Shaorong: Dean of College of life science and technology, Tongji University, Associate Dean, Graduate School of translational medicine, doctoral tutor. Research field: stem cell and somatic cell reprogramming.
Wang Yu: Chinese animal research institute researcher, doctoral tutor; State Key Laboratory of stem cell and reproductive biology of stem cells and small molecular laboratory, University of Science & Technology China part-time ph.d.. Research area: regenerative medicine and in vitro human clinical trials of small molecule drugs.
Liu Bing: Director, Department of oncology, Affiliated Hospital of Military Medical Science Academy of the PLA (307 Hospital). Stem cell development and cancer.
Li Wei: stem cell and cell cycle control research group leader, Institute of animal science, Chinese Academy of Sciences, research fellow. The mechanism and methods of stability and ploidy regulation of stem cell genome and the development and application of genome modification technology.